Fig. 1: Main epigenetic targets. | Experimental & Molecular Medicine

Fig. 1: Main epigenetic targets.

From: Targeting of epigenetic regulators in neuroblastoma

Fig. 1

Current inhibitors act on three different epigenetic levels: DNA methylation, histone methylation or acetylation, and chromatin reading. This scheme highlights the most promising drugs that target proteins involved in these processes with a subset already under clinical trials or even approved for treatment of certain malignancies

Back to article page